Psychedelic stocks are the new wave of investment buzz. It takes time to change people's minds, and it takes even more time regarding social taboos and essential socioeconomic issues. Now people are hoping to help with psychedelic problems, and some of the best psychedelic company stocks Canada could be growing exponentially.

The potential of psychedelic stocks in Canada:

About 5.4% of Canadians suffer from depression and 4.6% from anxiety. That is, about one in every ten people suffering from two of the most prevalent psychological problems can steal their ability to function correctly. The figure for the United States is 6.7% for major depressive disorder and 3.1% for generalized anxiety disorder, again about 10% of the population.

Many of these companies are traded on multiple exchanges in Canada,

• The Most Psychedelic Stocks in Canada on the CSE (CNSX)

• Several psychedelic stocks in NEO, TSXV and TSX.

Best psychedelic company stocks in Canada:

We still don't understand the legal psychedelic market and the period between legalization for medical use and legalization for recreational use.

Field trip health stock:

This Toronto Company take a slightly different approach to psychedelic. The company provides psychedelic psychotherapy services. This is the time when a certified doctor will take care of your messages and guide you through your 'journey'. They help you in your psychedelic exploration. It is considered an alternative treatment for depression, general anxiety and injury. The company has two locations in Canada and one European city. It is one of the few stocks on this list, trading relatively close to record highs.

Numinus wellness stock:

The Vancouver-based company has been around since 1964. The company also explored the field of psychedelic psychotherapy. But the company's services include ketamine therapy which is another psychedelic experience aimed at people with PTSD and substance use disorders. The company focuses more on natural forms of psychedelic drugs and does not rely on LSD.

Mind-Med stock:

Mind-Med is a New York-based cross-account company founded in 2019. It is one of the few psychedelic company stocks Canada, with a market capitalization of over $1 billion. The company has focused its research on the development of psychedelic-inspired drugs, which aims to maintain the healing powers of these substances while eliminating hallucinations.

Benefits of Psychedelic Stocks in Canada:

The benefits of investing in some of the best psychedelic company stocks Canada is start at an affordable price. So even with a small sum of money, you can buy the right amount of shares and wait for psychedelics to be legal. Because many companies serve both Canada and the United States, although psychedelic drugs are not approved here in Canada, The (federal) US state has already begun this process.

But, as you may have noticed, this is a cautionary tale in the form of shared stocks. It doesn't take much time for ads to drop and make your investment almost nothing. So be very careful about waiting too long before pulling out of the psychedelic spire. The most important flaw when it comes to psychedelic stocks is their instability. We don't know when this will be legal and how long you might have to wait and see for the positive movement in your psychedelic holdings.